| Ashley Underwood, CCC-SLP | |
|
1500 Spruce Ave Ofc, Red Clay Consolidated School District, Wilmington, DE 19805-2148 | |
| (302) 552-3797 | |
| Not Available |
| Full Name | Ashley Underwood |
|---|---|
| Gender | Female |
| Speciality | Speech-language Pathologist |
| Location | 1500 Spruce Ave Ofc, Wilmington, Delaware |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1013299734 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 235Z00000X | Speech-language Pathologist | 01-0001170 (Delaware) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Ashley Underwood, CCC-SLP 1500 Spruce Ave Ofc, Red Clay Consolidated School District, Wilmington, DE 19805-2148 Ph: (302) 552-3797 | Ashley Underwood, CCC-SLP 1500 Spruce Ave Ofc, Red Clay Consolidated School District, Wilmington, DE 19805-2148 Ph: (302) 552-3797 |
News Archive
Janssen-Cilag International NV announced today that the European Commission has approved INVOKANA (canagliflozin) in the European Union for the treatment of adults with type 2 diabetes mellitus, to improve glycaemic control[1]. Canagliflozin is an oral, once-daily medication, which belongs to a new class of medications called sodium glucose co-transporter 2 (SGLT2) inhibitors.
Dr. Jean-Philippe Gratton, Director of the Endothelial cell biology research unit at the Institut de recherches cliniques de Montr-al (IRCM), identifies a new intracellular mechanism responsible for modulating vascular permeability: the nitrosylation of beta-catenin protein by nitric oxide. This scientific breakthrough could have a possible impact on the treatment of cancerous tumours by altering the permeability of the blood vessels irrigating them. Dr. Gratton's team will publish the results of its research tomorrow in the scientific journal Molecular Cell.
The chemical (S)-N'-nitrosonornicotine, or (S)-NNN, which is present in smokeless tobacco products, is a strong oral carcinogen, according to results presented at the AACR Annual Meeting 2012, held here March 31 - April 4.
The first landmark randomized clinical trial for a cardiac drug regimen in Duchenne muscular dystrophy (DMD) is testing whether earlier treatment can stop or slow down heart damage that usually kills people with the disease.
› Verified 7 days ago
Allyson Jane Menard, SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 1600 Rockland Rd, Wilmington, DE 19803 Phone: 302-651-4200 Fax: 610-302-5618 | |
Elizabeth Golian Mccormick, Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 301 Mckennans Church Rd, Wilmington, DE 19808 Phone: 302-992-5520 | |
Karen A Jarosz-iler, SLP Speech-Language Pathologist Medicare: Accepting Medicare Assignments Practice Location: 43 Weilers Bnd, Wilmington, DE 19810 Phone: 518-479-7293 | |
Kathryn Mahoney, Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 700 N Lombard St, Wilmington, DE 19801 Phone: 302-429-4102 | |
Kalisandra G Bussey, Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 2000 Pennsylvania Ave Apt 436, Wilmington, DE 19806 Phone: 732-904-1886 | |
Nicole Rose Immediato, M.S., CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 5147 W Woodmill Dr Ste 21, Wilmington, DE 19808 Phone: 302-999-0702 |